Thursday, September 25, 2014

5 Best Defensive Stocks To Buy Right Now

Chalk up another strike against Big Tobacco. For a change, however, it isn't domestic tobacco producers that are on the defensive but global companies that could be facing a whirlwind of change if Russia, the world's third-largest tobacco market, is successful in implementing stringent anti-smoking laws.

Passed by Russian President Vladimir Putin in February and going into effect yesterday, new regulations ban smoking at schools and universities, in hospitals, sports facilities, and museums, and on public transportation. Smoking is predominantly banned in these areas already, but this is more of a uniform countrywide ban, as Reuters notes.


Source: MoneyBlogNews on Flickr.�

The real challenge is coming up next year, when the smoking contingencies widen to include a ban in cafes, restaurants, hotels, and street kiosks and will set a minimum countrywide price on a pack of cigarettes. Outside of mandating a new minimum price that would certainly be much higher than the current price, this is sounding awfully familiar to some of the policies enacted by California and the city of New York.

10 Best Up And Coming Stocks To Own For 2015: Home BancShares Inc.(HOMB)

Home BancShares, Inc. operates as a holding company for the Centennial Bank that provides various commercial and retail banking, and related financial products and services to businesses, real estate developers, investors, individuals, and municipalities. It offers various deposit products, including checking, savings, and money market accounts, as well as certificates of deposit. The company also offers commercial real estate, construction and land development, commercial and industrial, residential real estate, agricultural, and consumer loans. In addition, it provides Internet banking and voice response information, cash management, overdraft protection, direct deposit, safe deposit boxes, the United States savings bonds, and automatic account transfers services. Further, the company provides trust services focusing on personal trusts, corporate trusts, and employee benefit trusts, as well as writes insurance policies for commercial and personal lines of businesses. As of December 31, 2010, it operated 49 branches in Arkansas, 9 branches in the Florida Keys, 6 branches in central Florida, 3 branches in southwest Florida, and 29 branches in the Florida Panhandle. Home BancShares, Inc. is headquartered in Conway, Arkansas.

Advisors' Opinion:
  • [By Sean Williams]

    What: Shares of Home BancShares (NASDAQ: HOMB  ) , the holding company of Centennial Bank, jumped as much as 13% after receiving an analyst upgrade.

5 Best Defensive Stocks To Buy Right Now: General Motors Co (GM)

General Motors Company (GM), incorporated in on September 16, 1908, designs, builds and sells cars, trucks and automobile parts worldwide. The Company also provides automotive financing services through General Motors Financial Company, Inc. (GM Financial). It operates in four automotive segments: GM North America (GMNA), GM Europe (GME), GM International Operations (GMIO) and GM South America (GMSA). GM�� total worldwide vehicle sales were nine million during the year ended December 31, 2011. The Company�� GMNA segment develops, manufactures and/or markets vehicles under the brands, such as Buick, Cadillac, Chevrolet and GMC for its customers in North America. GM for its customers outside North America develops, manufactures and/or markets vehicles under the brands, such as Buick Chevrolet, GMC, Opel, Cadillac, Daewoo, Holden and Vauxhall. In March 2011, the Company announced the sale of its Class A Membership Interest in Delphi Automotive LLP (Delphi) back to Delphi. In October 2012, the Company bought back most of the 50% interest in its Indian operations that it had sold to Chinese partner SAIC Motor Corp Ltd and raised its interest in the venture to 93%.

Automotive

GMNA, with sales, manufacturing and distribution operations in the United States, Canada and Mexico and sales and distribution operations in Central America and the Caribbean, represented 32.4% of the Company�� vehicle sales volume in 2011. GME has sales, manufacturing and distribution operations across Western and Central Europe. GME's vehicle sales volume, which in addition to Western and Central Europe, includes Eastern Europe (including Russia and the other members of the Commonwealth of Independent States among others) represented 19.2% of its vehicle sales volume GMIO distributes Chevrolet brand vehicles which, when sold in Europe, are included in GME vehicle sales volume and market share data. GMIO has sales, manufacturing and distribution operations in Asia-Pacific, Eastern Europe (including Russ! ia and the other members of the Commonwealth of Independent States among others), Africa and the Middle East. GMIO represented 36.6% of the Company�� global vehicle sales volume, including sales through its joint ventures in 2011. GMSA, with sales, manufacturing and distribution operations in Brazil, Argentina, Colombia, Ecuador and Venezuela, as well as sales and distribution operations in Bolivia, Chile, Paraguay, Peru and Uruguay represented 11.8% of its vehicle sales volume in 2011. In 2011 GMSA derived 59.4% of its vehicle sales volume from Brazil.

As of December 31, 2011, the Company had equity ownership stakes directly or indirectly in entities through various regional subsidiaries, including GM Korea Company (GM Korea), Shanghai General Motors Co., Ltd. (SGM), SAIC-GM-Wuling Automobile Co., Ltd. (SGMW), FAW-GM Light Duty Commercial Vehicle Co., Ltd. (FAW-GM) and SAIC GM Investment Limited (HKJV). These companies design, manufacture and market vehicles under the brands, including Alpheon, Buick, Chevrolet, Jiefang, Baojun, Cadillac, Daewoo and Wuling. In addition to the products GM sells to its dealers for consumer retail sales, and also sells cars and trucks to fleet customers, including daily rental car companies, commercial fleet customers, leasing companies and Governments. It sells vehicles to fleet customers directly or through its network of dealers. The Company�� retail and fleet customers can obtain a range of after sale vehicle services and products through its dealer network, such as maintenance, light repairs, collision repairs, vehicle accessories and extended service warranties.

GM markets vehicles worldwide primarily through a network of independent authorized retail dealers. These outlets include distributors, dealers and authorized sales, service and parts outlets. The Company enters into a contract with each authorized dealer agreeing to sell to the dealer one or more specified product lines at wholesale prices and granting the dealer the right to ! sell thos! e vehicles to retail customers from an approved location. Authorized dealers offer parts, accessories, service and repairs for GM vehicles in the product lines that they sell using GM parts and accessories. Its dealers are authorized to service GM vehicles under its limited warranty program and those repairs are to be made only with GM parts. The Company also markets FlexFuel vehicles in Australia, Thailand and other markets.

GM produces compressed natural gas capable vehicles in Europe, such as the Opel Zafira, and in the United States, the Chevrolet Express and GMC Savana full-size vans are offered to fleet and commercial customers. It offers LPG capable vehicles in select markets in Europe, Asia Pacific, South America and North America. OnStar Corporation (OnStar) is a wholly owned subsidiary of GM serving more than six million subscribers in the United States, Canada and China. OnStar is a provider of connected safety, security and mobility solutions and information technology. OnStar's principal services include automatic crash response, stolen vehicle assistance, remote door unlock, turn-by-turn navigation, vehicle diagnostics and hands-free calling.

Automotive Financing - GM Financial

GM Financial specializes in purchasing retail automobile installment sales contracts originated by GM and non-GM franchised and independent dealers in connection with the sale of used and new automobiles. GM Financial also offers lease products through GM dealerships in connection with the sale of used and new automobiles. GM Financial primarily generates revenue through the purchase, retention, subsequent securitization and servicing of finance receivables. GM Financial earns finance charge income on finance receivables and pays interest expense on borrowings under its credit facilities. GM Financial periodically transfers receivables to securitization trusts that issue asset-backed securities to investors. In April 2011 GM Financial originated leases for the Company�� cust! omers in ! Canada.

Advisors' Opinion:
  • [By John Rosevear]

    At General Motors' (NYSE: GM  ) annual shareholders' meeting on Thursday, CEO Dan Akerson announced a new program: Buyers of new 2014 Chevrolet, Buick, and GMC vehicles will receive free routine maintenance for two years, or 24,000 miles.

  • [By Equity Options Guru]

    One of the hottest areas in automobile sales is electric cars. This is a very competitive area, with Tesla (TSLA) recently demonstrating its supremacy when it reported its first quarter earnings. In the earnings report, Tesla announced that it sold 4,900 of its Model S sedans. This sales figure made the Model S the top selling rechargeable car during the first quarter 2013 in North America. It surpassed the following leading automobile companies:

    General Motors (GM) sold 4,421 Volt plug-in hybridsNissan Motor (NSANY.OB) sold 3,695 Leaf vehicles

    What's troubling is that the Ford Focus Electric wasn't even mentioned. Even more concerning is that we can go back to total annual sales for 2012 of electric cars and Ford still doesn't make the list. The top 3 selling electric vehicles for 2012 were the Chevrolet Volt (owned by General Motors), the Toyota (TM) Prius Plug-In, and the Nissan Leaf.

  • [By Paul Ausick]

    For most of us, however, the mid-size car, compact car, compact crossover and full-size pickup segments are the likeliest choices for a new car purchase. Fully 60% of all vehicles sold to date in 2013 are listed in one of these segments. General Motors Co. (NYSE: GM), Ford Motor Co. (NYSE: F), Toyota Motor Corp. (NYSE: TM), Honda Motor Co. Ltd. (NYSE: HMC), and Chrysler Group are the sales leaders, and every one of these offers a variety of vehicles in each of the four best-selling segments.

  • [By Douglas A. McIntyre]

    Both Hyundai and VW have a great deal to lose as their market shares erode in the United States. VW claims it is on a path to pass General Motors Co. (NYSE: GM) and Toyota Motor Corp. (NYSE: TM) as the world’s largest car company. Hyundai’s sales put it in fourth place among all global manufacturers. It needs to have a growing share of the American market to keep that place as well.

5 Best Defensive Stocks To Buy Right Now: Town Sports International Holdings Inc.(CLUB)

Town Sports International Holdings, Inc., together with its subsidiaries, owns and operates fitness clubs in the northeast and mid-Atlantic regions of the United States. Its facilities include cardiovascular equipment; free weight and strength equipment; group exercise and cycling studios; the entertainment system network; locker rooms, including shower facilities and towel services; and other amenities, such as saunas, babysitting, and a pro-shop. The company also provides swimming pools, and racquet and basketball courts; and programs, which include small group training, children?s programs, and other programs targeting adult members. As of December 31, 2011, it operated 160 fitness clubs comprising 108 New York Sports Clubs, 25 Boston Sports Clubs, 18 Washington Sports Clubs, and 6 Philadelphia Sports Clubs, as well as 3 clubs located in Switzerland. The company is based in New York, New York.

Advisors' Opinion:
  • [By Seth Jayson]

    Town Sports International Holdings (Nasdaq: CLUB  ) reported earnings on July 24. Here are the numbers you need to know.

    The 10-second takeaway
    For the quarter ended June 30 (Q2), Town Sports International Holdings met expectations on revenues and met expectations on earnings per share.

  • [By gurujx]

    Town Sports International Holdings Inc (CLUB) Reached the 3-year Low of $5.82

    The prices of Town Sports International Holdings Inc (CLUB) shares have declined to close to the 3-year low of $5.82, which is 62.2% off the 3-year high of $14.96.

  • [By John Udovich]

    On Thursday, small cap fitness club owner Life Time Fitness, Inc (NYSE: LTM) lost some weight for investors as analysts gave the stock a workout after its Analyst Day failed to ease their concerns, meanings its worth taking a closer look at the stock along with the performance of Town Sports International Holdings, Inc (NASDAQ: CLUB)�and Steiner Leisure Ltd (NASDAQ: STNR).

5 Best Defensive Stocks To Buy Right Now: NeoStem Inc (NBS)

NeoStem, Inc., incorporated on September 18, 1980, operates in cellular therapy industry. Cellular therapy addresses the process by which new cells are introduced into a tissue to prevent or treat disease, or regenerate damaged or aged tissue, and consists of a separate therapeutic technology platform in addition to pharmaceuticals, biologics and medical devices. The Company�� business model includes the development of novel cell therapy products, as well as operating a contract development and manufacturing organization (CDMO) providing services to others in the regenerative medicine industry. Progenitor Cell Therapy, LLC, the Company�� wholly owned subsidiary (PCT), is a CDMO in the cellular therapy industry. PCT has provided pre-clinical and clinical current Good Manufacturing Practice (cGMP) development and manufacturing services to over 100 clients advancing regenerative medicine product candidates through rigorous quality standards all the way through to human testing.

PCT has two cGMP, cell therapy research, development, and manufacturing facilities in New Jersey and California, serving the cell therapy community with integrated and regulatory compliant distribution capabilities. Its core competencies in the cellular therapy industry include manufacturing of cell therapy-based products, product and process development, cell and tissue processing, regulatory support, storage, distribution and delivery and consulting services. The Company�� wholly-owned subsidiary, Amorcyte, LLC (Amorcyte) is developing its own cell therapy, AMR-001, for the treatment of cardiovascular disease. AMR-001 represents its clinically advanced therapeutic product candidate and enrollment for its Phase II PreSERVE clinical trial to investigate AMR-001's safety and efficacy in preserving heart function after a heart attack in a particular type of post Acute Myocardial Infarction (AMI) patients.

Through the Company�� subsidiary, Athelos Corporation (Athelos), the Company is collaborating w! ith Becton-Dickinson in early stage clinical development of a therapy utilizing T-cells, collaborating for autoimmune and inflammatory conditions, including but not limited to, graft vs. host disease, type 1 diabetes, steroid resistant asthma, lupus, multiple sclerosis and solid organ transplant rejection. The Company�� pre-clinical assets include its Very Small Embryonic Like (VSEL) Technology platform. The Company has basic research and development capabilities, manufacturing facilities on both the east and west coast of the United States.

Advisors' Opinion:
  • [By John Udovich]

    The results of a recent Pew Center Poll regarding attitudes towards abortion and various forms of stem cell research could be a good sign for the stem cell industry along with small cap stem cell stocks like StemCells Inc (NASDAQ: STEM), NeoStem Inc (NASDAQ: NBS), Neuralstem, Inc (NYSEMKT: CUR),�International Stem Cell Corp (OTCMKTS: ISCO) and BioRestorative Therapies (OTCBB: BRTX). Basically, Americans think that having an abortion is a moral issue with 49% of American adults believing abortion is morally wrong, 23%�view it not as a moral issue and and 15% view it as morally acceptable. However and when Americans were asked about issues surrounding�human embryos, such as stem cell research or in vitro fertilization, as a matter of morality, their views were different.

  • [By Roberto Pedone]

    Another under-$10 biopharmaceutical player that's starting to trend within range of triggering a big breakout trade is Neostem (NBS), engages in the development of proprietary cell therapy products. This stock has been hit hard by the sellers during the last three months, with shares off by 22%.

    If you take a look at the chart for Neostem, you'll notice that this stock has recently spiked higher back above both its 50-day moving average at $6.41 and its 200-day moving average of $6.60 a share. This move has also pushed shares of NBS back above some near-term overhead resistance levels at $6.57 to $6.98 a share. That move is quickly pushing NBS within range of triggering another breakout trade above some key near-term overhead resistance.

    Market players should now look for long-biased trades in NBS if it manages to break out above some near-term overhead resistance at $7.22 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action 327,514 shares. If that breakout triggers soon, then NBS will set up to re-fill some of its previous gap down zone from October that started just above $8 a share. If that that gap gets filled with volume, then NBS could easily tag its next major overhead resistance levels at $9 to $9.50 a share, or even its 52-week high at $9.89 a share.

    Traders can look to buy NBS off weakness to anticipate that breakout and simply use a stop that sits right below its 50-day moving average of $6.41 a share, or near more support at $6 a share. One can also buy NBS off strength once it takes out $7.22 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

  • [By John Udovich]

    From stem cell burgers to earnings reports, the stem cell industry and small cap players in it like NeoStem Inc (NASDAQ: NBS), International Stem Cell Corp (OTCMKTS: ISCO) and BioRestorative Therapies (OTCBB: BRTX) have been producing some news lately that has probably been overlooked by investors and traders alike given its August. Nevertheless, you might want to pay attention to the following stem cell news:

No comments:

Post a Comment